文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

心脏骤停后预防性使用抗生素:系统评价与Meta分析

Prophylactic antibiotic use following cardiac arrest: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2019-05-11
一句话结论心脏骤停后预防性/早期抗生素与临床驱动/延迟抗生素相比,未改变生存、神经功能预后、ICU住院时长或肺炎发生率。

该系统评价与Meta分析检索MEDLINE、EMBASE和Cochrane图书馆(截至2018年5月8日),纳入10篇文献共11项研究(3项随机对照试验、8项观察性研究),比较成人心脏骤停入院后预防性/早期抗生素(干预组)与临床驱动/延迟抗生素(对照组)对患者结局和感染结局的影响。结果显示干预与生存(OR 1.16,95%CI 0.97-1.40)、良好神经功能生存(OR 2.25,95%CI 0.93-5.45)、重症监护住院时长(均数差-0.6,95%CI -3.6至2.4)或肺炎发生率(OR 0.58,95%CI 0.23-1.46)均无显著关联,观察性研究与随机对照试验结果基本一致。作者认为可能需要进一步高质量试验来回答这一重要临床问题。

要点

  • 成人心脏骤停入院后预防性/早期抗生素与临床驱动/延迟抗生素相比,生存无显著差异(OR 1.16,95%CI 0.97-1.40)。
  • 良好神经功能生存无显著差异(OR 2.25,95%CI 0.93-5.45)。
  • 重症监护住院时长无显著差异(均数差-0.6,95%CI -3.6至2.4)。
  • 肺炎发生率无显著差异(OR 0.58,95%CI 0.23-1.46)。
  • 观察性研究与随机对照试验结果基本一致;作者认为可能需要进一步高质量试验。

适用人群与场景

  • 成人心脏骤停后入院患者。

研究设计与关键结果

  • 系统评价与Meta分析,纳入11项研究(3项随机对照试验、8项观察性研究),共10篇文献,检索MEDLINE、EMBASE和Cochrane图书馆至2018年5月8日。
  • 预防性/早期抗生素(干预组)与临床驱动/延迟抗生素(对照组)比较:生存OR 1.16(95%CI 0.97-1.40),无显著关联。
  • 良好神经功能生存OR 2.25(95%CI 0.93-5.45),无显著关联。
  • 重症监护住院时长均数差-0.6(95%CI -3.6至2.4),无显著关联。
  • 肺炎发生率OR 0.58(95%CI 0.23-1.46),无显著关联。
  • 观察性研究与随机对照试验结果基本一致。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入3项随机对照试验和8项观察性研究;使用Cochrane工具评估随机对照试验偏倚风险,使用GRADE工具评估观察性研究偏倚风险,总体证据质量采用GRADE系统评估(原文未报告具体证据等级)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 成人心脏骤停后入院患者中,预防性/早期抗生素与临床驱动/延迟抗生素相比未改变生存、良好神经功能生存、重症监护住院时长或肺炎发生率。
  • 作者认为可能需要进一步高质量试验来回答这一重要临床问题。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the effect of prophylactic/ early antibiotics (intervention group) compared with clinically driven/ delayed antibiotics (control group) on patient and infectious outcomes in adult cardiac arrest patients admitted to hospital.

DATA SOURCES: We searched MEDLINE (1946-current), EMBASE (1947-current) and the Cochrane library (inception-current) on 8th May 2018. Additional citations were identified through forward and backward citation tracking.

STUDY SELECTION: Two reviewers independently screened titles, abstracts, and full-texts. We included observational and interventional primary research studies with a concurrent or retrospective control group that were relevant to our study objective.

DATA EXTRACTION: We extracted data using a piloted data extraction form. Risk of bias was assessed using the Cochrane tool for randomised controlled trials or the GRADE tool for risk of bias in observational studies. Overall evidence quality for each outcome was assessed using the GRADE system.

DATA SYNTHESIS: Databases searches and citation tracking identified 6825 citations, of which ten citations containing 11 studies (3 randomised controlled trials, 8 observational studies) were eligible for inclusion. Data were summarised in meta-analyses using random-effect models. The intervention was not associated with increased survival (odds ratio 1.16, 95% CI 0.97-1.40), survival with good neurological outcome (odds ratio 2.25, 95% CI 0.93-5.45), critical care length of stay (mean difference -0.6, 95% CI -3.6 to 2.4) or incidence of pneumonia (odds ratio 0.58, 95% CI 0.23-1.46). Findings were generally consistent between observational studies and randomised controlled trials.

CONCLUSIONS: Antibiotic prophylaxis following cardiac arrest is not associated with a change in key clinical outcomes. Further high-quality trials may be needed to address this important clinical question. Review registration: PROSPERO CRD42016039358.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Couper K, Laloo R, Field R, et al. Prophylactic antibiotic use following cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2019. PMID: 31085216. doi:10.1016/j.resuscitation.2019.04.047

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。